| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |